Biota Ltd. develops proprietary pharmaceutical and nutraceutical oral film strips.

Biota’s innovative AlgiFilm™ film strips are simply administered onto or under the tongue (sublingually) without use of water, and adhere at oral mucosa surface and afterwards dissolve slowly due to hydration by the saliva.

AlgiFilm™ proprietary formulations enable to accomplish active ingredients’ trans-mucosal absorption that increase bioavailability and improve safety and effectiveness.

AlgiFilm™ first pharmaceutical product candidate is Cannabidiol (CBD) sublingual film strips.

CBD is a non-euphoric cannabinoid that interacts with the endocannabinoid system, influencing the circadian sleep/wake cycle, mood, autonomic function, anxiety, and pain.

AlgiFilm™ nutraceutical film strips are being developed and commercialized globally by Maabarot Products Ltd., a leading Israeli holding company.

Details about Maabarot Novel Film Technology (NFT) activities are available at https://novelfilmtechnology.com/

NFT portfolio include Saffron for emotional balance, Coenzyme Q₁₀ for energy and cardiovascular health, CBD, and other products.